MediLumine is committed to providing high quality instruments, reagents and accessories to support preclinical imaging programs in the life sciences. MediLumine’s PRISM™ series of in vivo imaging systems are designed for preclinical monitoring of physiological changes in living systems for therapeutic discovery research in universities and pharmaceutical companies. MediLumine’s Fenestra® and Mvivo™ contrast agents for micro-CT Imaging provide image enhancement for various applications allowing scientists to monitor progression of functional liver diseases, quantify tumor burdens, track cells in vivo and perform preclinical angiography.
View Top Employees from MediLumineWebsite | http://medilumine.com |
Revenue | $10 million |
Employees | 5 (5 on RocketReach) |
Founded | 2013 |
Address | 5795 Av de Gaspé, Suite #228, Montreal, Quebec H2S 2X3, CA |
Phone | (514) 929-9744 |
Fax | (514) 360-6014 |
Technologies |
JavaScript,
HTML,
Twitter
+19 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Business Services |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular MediLumine employee's phone or email?
The MediLumine annual revenue was $10 million in 2024.
Stephen Marchant is the Founder and Chief Executive Officer of MediLumine.
5 people are employed at MediLumine.
MediLumine is based in Montreal, Quebec.
The NAICS codes for MediLumine are [541, 541713, 54, 54171, 5417].
The SIC codes for MediLumine are [873, 87].